Since its appearance in the United States in 1999, West Nile virus (WNV) has caused the deaths of large numbers of birds and horses and close to 1000 humans. There is currently no effective therapy available, and a potent therapy is urgently needed. The goal of this project is to develop and evaluate the efficacy of recombinant human monoclonal antibodies for the prophylaxis and treatment of lethal WNV infection. We have produced recombinant human monoclonal single chain variable fragments (scFv) against the WNV envelope protein using a phage display screen, and characterized these antibodies both in vitro and in vivo. This procedure does not require immune selection, and can identify novel epitopes that are not normally recognized during infection or immunization with antigen - something that is not possible with other antibody development strategies. We have shown that these antibodies - particularly scFv #11, our model antibody for development - neutralize WNV and related flaviviruses in vitro, and are both protective before infection and therapeutic after infection in the mouse model of WNV. Here we propose to produce scFv#11 as a complete antibody and demonstrate its efficacy against WNV, as well as its cross-protective neutralization of dengue virus and other flaviviruses. In addition, we will produce and characterize additional recombinant antibodies to develop a synergistic combination of two antibodies for enhanced neutralization and therapy against WNV and other flavivirus infections. The recombinant antibodies will be fully human, produced rapidly and in high titer, free of blood-borne pathogens, and will be promising candidates for further development as a clinical reagent to combat flaviviral infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI070343-04
Application #
7655477
Study Section
Special Emphasis Panel (ZAI1-LR-M (M2))
Program Officer
Tseng, Christopher K
Project Start
2006-08-15
Project End
2011-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
4
Fiscal Year
2009
Total Cost
$1,286,788
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Troupin, Andrea; Londono-Renteria, Berlin; Conway, Michael J et al. (2016) A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection. Biochim Biophys Acta 1860:1898-909
Londono-Renteria, Berlin; Troupin, Andrea; Conway, Michael J et al. (2015) Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein. PLoS Pathog 11:e1005202
Chung, Lisa M; Ferguson, John P; Zheng, Wei et al. (2013) Differential expression analysis for paired RNA-Seq data. BMC Bioinformatics 14:110
Qian, Feng; Chung, Lisa; Zheng, Wei et al. (2013) Identification of genes critical for resistance to infection by West Nile virus using RNA-Seq analysis. Viruses 5:1664-81
Qian, Feng; Bolen, Christopher R; Jing, Chunxia et al. (2013) Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus. Clin Vaccine Immunol 20:146-55
Sultana, Hameeda; Neelakanta, Girish; Foellmer, Harald G et al. (2012) Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-?1/Smad6 signaling. J Immunol 189:3150-8
Chang, H; Biswas, S; Tallarico, A S et al. (2012) Human B-cell ontogeny in humanized NOD/SCID ýýc(null) mice generates a diverse yet auto/poly- and HIV-1-reactive antibody repertoire. Genes Immun 13:399-410
Colpitts, Tonya M; Conway, Michael J; Montgomery, Ruth R et al. (2012) West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev 25:635-48
Colpitts, Tonya M; Barthel, Sebastian; Wang, Penghua et al. (2011) Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells. PLoS One 6:e24365
Colpitts, Tonya M; Rodenhuis-Zybert, Izabela; Moesker, Bastiaan et al. (2011) prM-antibody renders immature West Nile virus infectious in vivo. J Gen Virol 92:2281-5

Showing the most recent 10 out of 26 publications